GlassScriptPhysician profile
Melaine Wade
NPI 1588070817
$871.95
in general payments reported to CMS, 2019-2025
16 companies · $271 in 2025
The $271 reported for 2025 was more than what 82% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $64.85 · 2023: $185 · 2024: $350 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $265.51 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $191.72 | 2023-2024 | Qelbree, Qelbree |
| Merck Sharp & Dohme LLC | $123.53 | 2022-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Hologic Sales and Service, LLC | $48.52 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Abbott Laboratories | $46.14 | 2025 | Freestyle Libre 3 |
| Averitas Pharma INC. | $26.87 | 2023 | Qutenza |
| Phadia US INC. | $24.12 | 2024 | Immunocap |
| Astellas Pharma US INC | $22.16 | 2023 | Veozah |
| Recor Medical INC | $21.78 | 2025 | Paradise Ultrasound Renal Denervation System |
| Otsuka America Pharmaceutical, INC. | $18.46 | 2025 | Rexulti |
| Glaxosmithkline, LLC. | $16.58 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.39 | 2025 | Airsupra |
| Boston Scientific Corporation | $15.04 | 2024 | Watchman Flx |
| Exact Sciences Corporation | $13.99 | 2023 | Cologuard Collection Kit |
| Novo Nordisk INC | $13.28 | 2023 | Rybelsus, Ozempic |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $8.86 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melaine Wade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.